Home » Drugmaker Warned for Unapproved Promotion, AE Reporting Failures
Drugmaker Warned for Unapproved Promotion, AE Reporting Failures
Crescendo Therapeutics has been warned for marketing a scar-removal drug lacking FDA approval and without a documented postmarket adverse drug experience reporting system.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May